PTC THERAPEUTICS INC's ticker is PTCT and the CUSIP is 69366J200. A total of 181 filers reported holding PTC THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.85 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,027,615 | -29.5% | 179,724 | +27.9% | 0.00% | -50.0% |
| Q2 2023 | $5,714,216 | +267.2% | 140,502 | +337.3% | 0.00% | +100.0% |
| Q1 2023 | $1,556,280 | +443.8% | 32,128 | +328.5% | 0.00% | – |
| Q4 2022 | $286,199 | -81.5% | 7,498 | -75.7% | 0.00% | -100.0% |
| Q3 2022 | $1,547,000 | -10.0% | 30,820 | -28.2% | 0.00% | 0.0% |
| Q2 2022 | $1,719,000 | +136.5% | 42,911 | +120.3% | 0.00% | – |
| Q1 2022 | $727,000 | +97.0% | 19,477 | +109.7% | 0.00% | – |
| Q4 2021 | $369,000 | -14.4% | 9,290 | -19.7% | 0.00% | – |
| Q3 2021 | $431,000 | -34.2% | 11,576 | -25.3% | 0.00% | – |
| Q2 2021 | $655,000 | -55.8% | 15,500 | -50.5% | 0.00% | – |
| Q1 2021 | $1,482,000 | -32.2% | 31,292 | -12.7% | 0.00% | -100.0% |
| Q4 2020 | $2,187,000 | -38.9% | 35,836 | -53.2% | 0.00% | -50.0% |
| Q3 2020 | $3,577,000 | -29.3% | 76,507 | -23.2% | 0.00% | -50.0% |
| Q2 2020 | $5,058,000 | +1674.7% | 99,681 | +1457.5% | 0.00% | – |
| Q1 2020 | $285,000 | -39.2% | 6,400 | -34.4% | 0.00% | -100.0% |
| Q4 2019 | $469,000 | -55.9% | 9,756 | -69.0% | 0.00% | -50.0% |
| Q3 2019 | $1,064,000 | +383.6% | 31,451 | +542.1% | 0.00% | – |
| Q2 2019 | $220,000 | -32.9% | 4,898 | -43.8% | 0.00% | -100.0% |
| Q1 2019 | $328,000 | -65.6% | 8,719 | -57.1% | 0.00% | 0.0% |
| Q3 2018 | $954,000 | +61.7% | 20,306 | -6.8% | 0.00% | -50.0% |
| Q1 2018 | $590,000 | -85.1% | 21,790 | -89.0% | 0.00% | -84.6% |
| Q3 2017 | $3,961,000 | +2076.4% | 197,968 | +1085.4% | 0.01% | +1200.0% |
| Q4 2016 | $182,000 | -76.9% | 16,700 | -70.3% | 0.00% | -75.0% |
| Q3 2016 | $787,000 | +719.8% | 56,200 | +311.1% | 0.00% | – |
| Q2 2016 | $96,000 | -80.9% | 13,669 | -82.5% | 0.00% | -100.0% |
| Q1 2016 | $502,000 | +141.3% | 77,915 | +1112.7% | 0.00% | +200.0% |
| Q4 2015 | $208,000 | -96.1% | 6,425 | -96.8% | 0.00% | -97.0% |
| Q3 2015 | $5,289,000 | +1037.4% | 198,100 | +2495.3% | 0.03% | +725.0% |
| Q1 2015 | $465,000 | -0.9% | 7,633 | -57.5% | 0.00% | -33.3% |
| Q2 2014 | $469,000 | – | 17,947 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Burrage Capital Management LLC | 161,083 | $9,831,000 | 7.49% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 333,000 | $20,323,000 | 5.55% |
| RTW INVESTMENTS, LP | 4,221,836 | $257,659,000 | 4.32% |
| GEORGE KAISER FAMILY FOUNDATION | 90,011 | $10,766,000 | 2.85% |
| SECTORAL ASSET MANAGEMENT INC | 603,978 | $36,861,000 | 2.60% |
| Redwood Investments, LLC | 364,837 | $22,266,000 | 1.90% |
| ARMISTICE CAPITAL, LLC | 716,000 | $43,697,000 | 1.49% |
| CM Management, LLC | 25,000 | $1,526,000 | 1.42% |
| Third Security, LLC | 237,015 | $14,465,000 | 1.32% |
| Sofinnova Investments, Inc. | 316,478 | $19,315,000 | 1.15% |